...BRCA2, p53, PTEN, CHEK2 and ATM. Surgery, chemotherapy, radiotherapy and hormone therapy are used ...
Hereditary breast cancer accounts for about 10% of all breast cancers and BRCA1 and BRCA2 genes have been identified as ...
...BRCA2 mutations, and the most effective risk-reducing strategies.,Women with BRCA-associated epithelial ovarian cancer r...
In Western countries, the mutation status of the BRCA1 and BRCA2 genes is commonly determined for genetic counseling amo...
...BRCA2) among men who undergo genetic testing.,A cross-sectional study compared 51 mutation carriers with 30 men who test...
...BRCA2 did not potentiate the cytotoxic effect of treatment with PARPi and topotecan. With loss of function of ATM, other...
...BRCA2 has created great interest and expectations among members of families with a positive history for breast/ovarian c...
...BRCA2 mutation were invited to participate. Participants completed three questionnaires (SF-12(®) Health Survey, Brief S...
...BRCA2 and one in BRCA1) representing 4.5% of the total. Two unrelated patients were found to have a BRCA2 5531delTT muta...
...BRCA2-associated ovarian or breast cancers, and in combination with chemotherapy in triple negative breast cancer. This ...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269